Singapore markets closed
  • Straits Times Index

    3,095.59
    -6.62 (-0.21%)
     
  • Nikkei

    25,935.62
    -457.42 (-1.73%)
     
  • Hang Seng

    21,859.79
    -137.10 (-0.62%)
     
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • BTC-USD

    19,068.21
    -134.99 (-0.70%)
     
  • CMC Crypto 200

    420.84
    +0.70 (+0.17%)
     
  • S&P 500

    3,825.33
    +39.95 (+1.06%)
     
  • Dow

    31,097.26
    +321.83 (+1.05%)
     
  • Nasdaq

    11,127.84
    +99.11 (+0.90%)
     
  • Gold

    1,812.90
    +5.60 (+0.31%)
     
  • Crude Oil

    108.46
    +2.70 (+2.55%)
     
  • 10-Yr Bond

    2.8890
    -0.0830 (-2.79%)
     
  • FTSE Bursa Malaysia

    1,449.74
    +5.52 (+0.38%)
     
  • Jakarta Composite Index

    6,794.33
    -117.25 (-1.70%)
     
  • PSE Index

    6,165.35
    +9.92 (+0.16%)
     

INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of LifeStance Health Group, Inc. (LFST) Investors

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, November 11, 2021--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST). The investigation concerns whether LifeStance has violated the federal securities laws and/or engaged in other unlawful business practices.

LifeStance is one of the nation’s largest providers of virtual and in-person outpatient mental health care for children, adolescents, and adults experiencing a variety of mental health conditions. The Company has promoted itself as being dedicated to improving the lives of patients by reimagining mental health through a disruptive, tech-enabled in-person and virtual care delivery model built to expand access and affordability, improve outcomes, and lower overall health care costs.

On August 11, 2021, LifeStance reported that the Company’s Q2 2021 net loss more than doubled compared to the previous year’s quarter and estimated Q3 2021 revenues which lagged analysts’ consensus. During the earnings call that day, senior management in part blamed increased clinician turnover for the downward pressure on financial performance, disclosed they saw this trend midway through Q2 2021, and explained that new clinicians would be less productive for up to six months.

On this news, the Company’s share price declined by $10.16 per share, or approximately 46.46%, from $21.87 per share to close at $11.71 per share on August 12, 2021.

Then, on November 8, 2021, after the market closed, LifeStance announced its third quarter 2021 financial results, reporting net loss of $120.5 million compared to a net loss of $3.3 million the prior year.

On this news, the Company’s share price declined by $3.10 per share, or approximately 24.2%, from $12.83 per share to close at $9.73 per share on November 9, 2021.

If you purchased or otherwise acquired LifeStance securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211111006099/en/

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-371-6600
https://www.kmllp.com
investigations@kmllp.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting